LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 97 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $158,000 | +3.3% | 62,869 | +17.3% | 0.01% | +12.5% |
| Q2 2021 | $153,000 | +48.5% | 53,609 | +21.8% | 0.01% | +33.3% |
| Q1 2021 | $103,000 | +68.9% | 44,013 | +26.6% | 0.01% | +50.0% |
| Q4 2020 | $61,000 | -3.2% | 34,771 | -48.5% | 0.00% | +100.0% |
| Q3 2020 | $63,000 | -33.0% | 67,532 | -37.6% | 0.00% | 0.0% |
| Q2 2020 | $94,000 | -4.1% | 108,280 | -9.0% | 0.00% | -33.3% |
| Q1 2020 | $98,000 | -31.0% | 118,935 | -25.4% | 0.00% | +50.0% |
| Q4 2019 | $142,000 | – | 159,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,005,379 | $85,694,000 | 4.37% |
| Defender Capital, LLC. | 4,798,270 | $12,707,000 | 4.13% |
| Raffles Associates | 93,590 | $236,000 | 0.22% |
| Prescott General Partners LLC | 1,851,851 | $4,667,000 | 0.16% |
| DCF Advisers, LLC | 87,000 | $219,000 | 0.10% |
| Laidlaw Wealth Management LLC | 104,841 | $264,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $113,000 | 0.06% |
| Strategic Wealth Investment Group, LLC | 70,625 | $179,000 | 0.05% |
| Fort Sheridan Advisors LLC | 47,931 | $121,000 | 0.04% |
| Sightline Wealth Advisors, LLC | 14,958 | $38,000 | 0.03% |